- Home
- DBI vs JSPR Comparison
DBI vs JSPR Comparison
Compare DBI & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DBI
- JSPR
- Stock Information
- Founded
- DBI 1991
- JSPR 2018
- Country
- DBI United States
- JSPR United States
- Employees
- DBI N/A
- JSPR N/A
- Industry
- DBI Clothing/Shoe/Accessory Stores
- JSPR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DBI Consumer Discretionary
- JSPR Health Care
- Exchange
- DBI Nasdaq
- JSPR Nasdaq
- Market Cap
- DBI 292.2M
- JSPR 325.7M
- IPO Year
- DBI 1991
- JSPR N/A
- Fundamental
- Price
- DBI $5.47
- JSPR $22.09
- Analyst Decision
- DBI Hold
- JSPR Strong Buy
- Analyst Count
- DBI 2
- JSPR 11
- Target Price
- DBI $5.75
- JSPR $73.38
- AVG Volume (30 Days)
- DBI 2.1M
- JSPR 184.2K
- Earning Date
- DBI 12-10-2024
- JSPR 11-07-2024
- Dividend Yield
- DBI 3.68%
- JSPR N/A
- EPS Growth
- DBI N/A
- JSPR N/A
- EPS
- DBI N/A
- JSPR N/A
- Revenue
- DBI $3,050,038,000.00
- JSPR N/A
- Revenue This Year
- DBI N/A
- JSPR N/A
- Revenue Next Year
- DBI $2.23
- JSPR N/A
- P/E Ratio
- DBI N/A
- JSPR N/A
- Revenue Growth
- DBI N/A
- JSPR N/A
- 52 Week Low
- DBI $4.36
- JSPR $5.02
- 52 Week High
- DBI $11.57
- JSPR $31.01
- Technical
- Relative Strength Index (RSI)
- DBI 46.98
- JSPR 52.60
- Support Level
- DBI $5.18
- JSPR $20.77
- Resistance Level
- DBI $6.21
- JSPR $22.63
- Average True Range (ATR)
- DBI 0.43
- JSPR 1.55
- MACD
- DBI -0.05
- JSPR -0.03
- Stochastic Oscillator
- DBI 42.47
- JSPR 64.51
About DBI Designer Brands Inc.
Designer Brands Inc is a designer, producer, and retailer of footwear and accessories. The company operates in three reportable segments: the U.S. Retail segment, the Canada Retail segment, and the Brand Portfolio segment. The U.S. Retail segment operates the DSW Designer Shoe Warehouse banner through its direct-to-consumer U.S. stores and e-commerce site. The Canada Retail segment operates The Shoe Company and DSW banners through its direct-to-consumer Canada stores and e-commerce sites. The Brand Portfolio segment earns revenue from the sale of wholesale products to retailers, commissions for serving retailers as the design and buying agent for products under private labels, and the sale of branded products through its direct-to-consumer e-commerce sites.
About JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.